Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 793–816 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Epilepsy, Epilepsy Intractable, Epilepsy, Temporal Lobe
Interventions: 3T Magnetic Resonance Imaging, Intracranial electroencephalography recordings, 7T Magnetic Resonance Imaging; Diagnostic Test
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 290 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Opioid Use, Alcohol Use Disorder
Interventions: repetitive transcranial magnetic stimulation (rTMS) for AUD, repetitive transcranial magnetic stimulation (rTMS) for OUD; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Concussion
Interventions: Nautilus BrainPulse Recording; Device
Lead sponsor: Jan Medical, Inc.; Industry
Eligibility: 10 Years to 25 Years
Enrollment: 149 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 4
States / cities: Fort Lauderdale, Florida • Munster, Indiana • Baton Rouge, Louisiana + 1 more

Conditions: Leukemia, Lymphoma
Interventions: Total Lymphoid Irradiation, Fludarabine, Cyclophosphamide, Thiotepa, Melphalan, HPC,A Infusion, TC-NK Infusion, G-CSF, Mesna, CliniMACS, Mycophenolate mofetil; Radiation · Drug · Biological + 1 more
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Treatment Resistant Depression
Interventions: Active Low Field Magnetic Stimulation, Sham Low Field Magnetic Stimulation; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Bariatric Surgery Candidate, Heart Failure, Cardiovascular Diseases
Interventions: MRI; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Alzheimer Disease, Early Onset, Dementia, Alzheimer Disease
Interventions: Device Implantation- Boston Scientific, VERCISE GENUS™ system, DBS Stimulation - Boston Scientific, VERCISE GENUS™ system; Procedure · Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 60 Years to 80 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Alcohol Use, Unspecified
Interventions: Episodic Future thinking, Volitional choice, Monitoring only; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Fat Reduction, Muscle Tone Increased
Interventions: EMS, 1064 nm diode laser, RF/PEMF; Device
Lead sponsor: Venus Concept; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: San Diego, California • Hackensack, New Jersey • Nashville, Tennessee

Conditions: Dementia, Alzheimer's Disease, Depression
Interventions: Tele-Savvy, iPad; Behavioral · Other
Lead sponsor: Emory University; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Posttraumatic Stress Disorder, Major Depressive Disorder
Interventions: Positive Processes and Transition to Health, Progressive Muscle Relaxation; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Newark, Delaware • Cleveland, Ohio • Seattle, Washington

Conditions: Breast Cancer
Interventions: MRI, RSI; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Oligometastatic Disease
Interventions: 18-F-NaF Cardiac PET/MRI and, CT Angiogram; Diagnostic Test
Lead sponsor: Katelyn Atkins; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Actinic Keratoses
Interventions: Combination field therapy with 5-fluorouracil and calcipotriene (5FU/C); Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Cleveland, Ohio

Conditions: Atrial Fibrillation
Interventions: Pulsed Field Ablation (PFA); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 6
States / cities: Jonesboro, Arkansas • Boston, Massachusetts • New York, New York + 1 more

Conditions: Shin Splint, Running-related Injury
Interventions: In-Field Gait-Training, Home Exercise; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Upper Gastrointestinal Hemorrhage
Interventions: Over-the-scope hemoclipping device, Standard endoscopic treatment; Device · Other
Lead sponsor: CURE Digestive Diseases Research Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2025
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Parkinson Disease
Interventions: Neural recordings and stimulation; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 40 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Fat Disorder
Interventions: BTL-899; Device
Lead sponsor: BTL Industries Ltd.; Industry
Eligibility: 22 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Overactive Bladder (OAB)
Interventions: Wearable neurostimulation system for saphenous nerve stimulation, tolterodine tartrate 4 mg extended release; Device · Drug
Lead sponsor: NinaMED Pty Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Intraoperative Bleeding
Interventions: Epinephrin, 1% lidocaine with epinephrin 1:100,000, Saline; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Autism Spectrum Disorder, Asperger Disorder, Pervasive Developmental Disorder
Interventions: TMS and functional MRI (Magstim); Device
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Tourette Syndrome
Interventions: Transcranial Magnetic Stimulation, Comprehensive behavioral intervention; Device · Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 85 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pain, Postoperative, Morbid Obesity
Interventions: Injected bupivacaine post-operatively, Streamed bupivacaine versus streamed normal saline, Aerosolized bupivacaine versus aerosolized saline, Injected lidocaine pre-incision vs saline pre-incision; Drug
Lead sponsor: Pinnacle Health System; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Harrisburg, Pennsylvania

Search by objective public record fields.

Localizing Epileptic Networks Using MRI and iEEG

rTMS as Add on Treatment for Substance Use Disorders

A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion

Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy

Low Field Magnetic Stimulation for Treatment Resistant Depression

CV Imaging of Metabolic Interventions

Cholinergic Deep Brain Stimulation for Alzheimer's Disease

Behavioral Economic Treatment to Enhance Rural (BETTER) Living

Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program

Positive Processes and Transition to Health (PATH)

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography

5-Fluorouracil and Calcipotriene for Field Treatment of Actinic Keratoses

Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

Gait-Training Using Wearable Sensors

Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage

Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation

Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs

Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder

Effects of Adrenaline Infiltration on Surgical Field of View in Endoscopic Sinus Surgery

Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies

Combined CBIT and rTMS to Improve Tourette's Syndrome

Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic